Fairvalue-Calculator Fairvalue-Calculator
EN DE

M1 Kliniken AG (M12) Fair Value & Analysis

Healthcare · DE · Market cap €357M

Price€18.28
Fair Value€26.90
Upside+47.2%
Quality80/100
Evidence: Medium Range €19.45 – €34.53

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

M1 Kliniken AG (M12) currently trades at €18.28, while our model-based Fair Value estimate is €26.90 — implying the stock looks roughly 47.2% undervalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, Croatia, Hungary, Bulgaria, and Romania. It operates through Beauty and Trade segments. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas of oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG.

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) -81% Cencora, Inc (C1CO34) -89% Cardinal Health, Inc (CAH) -38% Sigma Healthcare Limited (SIGGF) -67% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +112%

Frequently asked questions

Is M1 Kliniken AG (M12) undervalued?
As of Jun 24, 2026, our model estimates a fair value of €26.90 versus a price of €18.28 — about +47% (undervalued). Model-based estimate, not financial advice.
What is the fair value of M12?
Our 21-model fair value for M1 Kliniken AG is €26.90 (as of Jun 24, 2026), built from audited fundamentals. The current price is €18.28.
What is the quality score of M12?
M1 Kliniken AG has a Quality Score of 80/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.